John E. Orth - 31 Mar 2025 Form 4 Insider Report for Ryerson Holding Corp (RYI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Apr 2025, 21:02:40 UTC
Prior SEC filing
24 Mar 2025
Next SEC filing
23 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Camilla Rykke Merrick, attorney-in-fact

Key filing fact

John E. Orth filed Form 4 for Ryerson Holding Corp (RYI) on 02 Apr 2025.

Key facts

  • This page summarizes John E. Orth's Form 4 filing for Ryerson Holding Corp (RYI).
  • 9 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2025, 21:02.

Change

  • Previous filing in this sequence was filed on 24 Mar 2025.
  • Current net transaction value: -$174,312.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RYI transaction

Common Stock (par value $0.01 per share)

Options Exercise

Transaction value
$0
Shares
+1,785
Change %
+2.7%
Price
$0.000000
Shares after
67,953
Date
31 Mar 2025
Ownership
Direct
Footnotes
F1, F13
RYI transaction

Common Stock (par value $0.01 per share)

Options Exercise

Transaction value
$0
Shares
+2,039
Change %
+3%
Price
$0.000000
Shares after
69,992
Date
31 Mar 2025
Ownership
Direct
Footnotes
F1, F13
RYI transaction

Common Stock (par value $0.01 per share)

Options Exercise

Transaction value
$0
Shares
+1,994
Change %
+2.8%
Price
$0.000000
Shares after
71,986
Date
31 Mar 2025
Ownership
Direct
Footnotes
F1, F13
RYI transaction

Common Stock (par value $0.01 per share)

Options Exercise

Transaction value
$0
Shares
+10,050
Change %
+14%
Price
$0.000000
Shares after
82,036
Date
31 Mar 2025
Ownership
Direct
Footnotes
F2
RYI transaction

Common Stock (par value $0.01 per share)

Tax liability

Transaction value
$174,312
Shares
-7,592
Change %
-9.3%
Price
$22.96
Shares after
74,444
Date
31 Mar 2025
Ownership
Direct
Footnotes
F12

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RYI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,785
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,785
Exercise price
Footnotes
F3, F4, F5, F6, F13, F14
RYI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,039
Change %
-50%
Price
$0.000000
Shares after
2,040
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,039
Exercise price
Footnotes
F3, F4, F7, F8, F13
RYI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,994
Change %
-33%
Price
$0.000000
Shares after
3,990
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,994
Exercise price
Footnotes
F3, F4, F9, F10, F13
RYI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+6,600
Change %
Price
$0.000000
Shares after
6,600
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,600
Exercise price
Footnotes
F3, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

Represents shares received upon the vesting of restricted stock units and shares received upon the vesting of dividend equivalent rights granted in connection with the quarterly dividends declared by Ryerson Holding Corporation (the "Company"). Dividend equivalent rights are subject to the same terms and conditions, including vesting, as the underlying restricted stock units.

Footnote F2

Represents shares received or that will be received in respect of performance-based restricted stock units granted on March 31, 2022. Each performance-based restricted stock unit became vested on March 31, 2025, which was the later of (i) the third anniversary of the grant date and (ii) the date the compensation committee certified the achievement of the applicable performance objectives in accordance with the underlying award agreement. The compensation committee certified the achievement of the applicable performance objectives on March 31, 2025. Vested shares will be delivered to the reporting person not later than 60 days following the vesting date.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of common stock of the Company.

Footnote F4

The restricted stock units reported as disposed herein were settled for shares of common stock of the Company.

Footnote F5

On March 31, 2022, the reporting person was granted 4,950 restricted stock units, of which 1,650 vested on the first anniversary of the grant date, 1,650 vested on the second anniversary of the grant date and 1,650 vested on the third anniversary of the grant date. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F6

Settlement of dividend equivalent rights in connection with the vesting of underlying restricted stock units that were granted on March 31, 2022. The dividend equivalent rights accrued when and as the Company declared quarterly dividends and vested proportionately with the restricted stock unit to which they related. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F7

On March 31, 2023, the reporting person was granted 5,775 restricted stock units, of which 1,925 vested on the first anniversary of the grant date and 1,925 vested on the second anniversary of the grant date. All 1,925 of the remaining unvested restricted stock units will vest on the third anniversary of the grant date. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F8

Settlement of dividend equivalent rights in connection with the vesting of underlying restricted stock units that were granted on March 31, 2023. The dividend equivalent rights accrued when and as the Company declared quarterly dividends and vested proportionately with the restricted stock unit to which they related. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F9

On March 31, 2024, the reporting person was granted 5,775 restricted stock units, of which 1,925 vested on the first anniversary of the grant date. Of the remaining unvested restricted stock units, 1,925 will vest on the second anniversary of the grant date and 1,925 will vest on the third anniversary of the grant date. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F10

Settlement of dividend equivalent rights in connection with the vesting of underlying restricted stock units that were granted on March 31, 2024. The dividend equivalent rights accrued when and as the Company declared quarterly dividends and vested proportionately with the restricted stock unit to which they related. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F11

On March 31, 2025, the reporting person was granted 6,600 restricted stock units, of which 2,200 will vest on the first anniversary of the grant date, 2,200 will vest on the second anniversary of the grant date and 2,200 will vest on the third anniversary of the grant date. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.

Footnote F12

Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.

Footnote F13

The number of dividend equivalent rights settled in connection with the vesting of underlying restricted stock units has been rounded to a whole number. This reflects a change in the reporting methodology.

Footnote F14

The number of restricted stock units owned by the reporting person following the reported transaction has been rounded to a whole number. This reflects a change in the reporting methodology.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .